Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec;280(24):6354-66.
doi: 10.1111/febs.12446. Epub 2013 Aug 19.

Sphingosine-1-phosphate receptor 2

Mohamad Adada  1 , Daniel Canals, Yusuf A Hannun, Lina M Obeid
Affiliations
Review

Sphingosine-1-phosphate receptor 2

Mohamad Adada et al. FEBS J. 2013 Dec.

Abstract

Sphingosine-1-phosphate (S1P) is a potent bioactive sphingolipid involved in cell proliferation, angiogenesis, inflammation and malignant transformation among other functions. S1P acts either directly on intracellular targets or activates G protein-coupled receptors, specifically five S1P receptors (S1PRs). The identified S1PRs differ in cellular and tissue distribution, and each is coupled to specific G proteins, which mediate unique functions. Here, we describe functional characteristics of all five receptors, emphasizing S1PR2, which is critical in the immune, nervous, metabolic, cardiovascular, musculoskeletal, and renal systems. This review also describes the role of this receptor in tumor growth and metastasis and suggests potential therapeutic avenues that exploit S1PR2.

Keywords: JTE013; S1P knockout mouse; S1PR2; SID46371153; cancer; ceramide; ezrin; sphingolipid diseases; sphingolipids; sphingosine 1-phosphate.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A) Schematic representation of the sphingolipids metabolic pathway. (B) The different biological functions downstream of S1PR2.
See this image and copyright information in PMC

References

    1. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9:139–150. - PubMed
    1. Hannun YA, Obeid LM. Many ceramides. J Biol Chem. 2011;286:27855–27862. - PMC - PubMed
    1. Zitomer NC, Mitchell T, Voss KA, Bondy GS, Pruett ST, Garnier-Amblard EC, Liebeskind LS, Park H, Wang E, Sullards MC, et al. Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals. J Biol Chem. 2009;284:4786–4795. - PMC - PubMed
    1. Penno A, Reilly MM, Houlden H, Laura M, Rentsch K, Niederkofler V, Stoeckli ET, Nicholson G, Eichler F, Brown RH, Jr, et al. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem. 2010;285:11178–11187. - PMC - PubMed
    1. Lingwood CA. Glycosphingolipid functions. Cold Spring Harb Perspect Biol. 2011;3 doi:10.1101/cshperspect.a004788. - PMC - PubMed

Publication types